MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

MYND Life Sciences Inc.  is pleased and extremely grateful to acknowledge the financial contribution from the Government of Canada towards an important component of its research and development into the positive effects of psilocybin on treating diseases of the brain.

Category Press Release
Country Canada

Companies Featured

Mynd Life Sciences
Mynd aim to establish the link between depression and inflammation in the brain and ultimately therapeutically target this link using compounds found in psilocybin.